dihydroxyphenylalanine has been researched along with Depressive Disorder, Major in 4 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Depressive Disorder, Major: Disorder in which five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. Symptoms include: depressed mood most of the day, nearly every daily; markedly diminished interest or pleasure in activities most of the day, nearly every day; significant weight loss when not dieting or weight gain; Insomnia or hypersomnia nearly every day; psychomotor agitation or retardation nearly every day; fatigue or loss of energy nearly every day; feelings of worthlessness or excessive or inappropriate guilt; diminished ability to think or concentrate, or indecisiveness, nearly every day; or recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt. (DSM-5)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Howes, OD | 1 |
Williams, M | 1 |
Ibrahim, K | 1 |
Leung, G | 1 |
Egerton, A | 1 |
McGuire, PK | 1 |
Turkheimer, F | 1 |
Conway, CR | 1 |
Chibnall, JT | 1 |
Cumming, P | 1 |
Mintun, MA | 1 |
Gebara, MA | 1 |
Perantie, DC | 1 |
Price, JL | 1 |
Cornell, ME | 1 |
McConathy, JE | 1 |
Gangwani, S | 1 |
Sheline, YI | 1 |
Salazar, G | 1 |
Cuello, D | 1 |
Fragoso, M | 1 |
Benlloc, L | 1 |
TURNER, WJ | 1 |
MERLIS, S | 1 |
1 trial available for dihydroxyphenylalanine and Depressive Disorder, Major
Article | Year |
---|---|
Antidepressant response to aripiprazole augmentation associated with enhanced FDOPA utilization in striatum: a preliminary PET study.
Topics: Adult; Animals; Antidepressive Agents; Aripiprazole; Caudate Nucleus; Citalopram; Corpus Striatum; D | 2014 |
3 other studies available for dihydroxyphenylalanine and Depressive Disorder, Major
Article | Year |
---|---|
Midbrain dopamine function in schizophrenia and depression: a post-mortem and positron emission tomographic imaging study.
Topics: Adult; Depressive Disorder, Major; Dihydroxyphenylalanine; Dopamine; Dopamine Agents; Female; Humans | 2013 |
Neuropsychiatric symptoms in Lewy body diffuse disease: a case report.
Topics: Aged; Antidepressive Agents; Cognition Disorders; Depressive Disorder, Major; Dihydroxyphenylalanine | 2011 |
A CLINICAL TRIAL OF PARGYLINE AND DOPA IN PSYCHOTIC SUBJECTS.
Topics: Adolescent; Biomedical Research; Brain; Brain Damage, Chronic; Depression; Depressive Disorder, Majo | 1964 |